跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
NUROFEN ZAVANCE 256mg ibuprofen sodium sugar coated tablet blister pack
Approved
STANDARD
NUROFEN ZAVANCE 256mg ibuprofen sodium sugar coated tablet blister pack
Reckitt Benckiser Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 28, 2025
Approval ID
4270d2b355b3131c
Company
Reckitt Benckiser Pty Ltd
Type
Standard
Approval Details
Approval Id
4270d2b355b3131c
Product Name
NUROFEN ZAVANCE 256mg ibuprofen sodium sugar coated tablet blister pack
Artg Id
156293
Artg Name
NUROFEN ZAVANCE 256mg ibuprofen sodium sugar coated tablet blister pack
Sponsor
Reckitt Benckiser Pty Ltd
Company Detail Path
/organization/reckitt-benckiser-australia-pty-ltd
Artg Date
2008-10-28
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 28, 2025
Approval ID
4270d2b355b3131c
Type
Standard
Back to TGA Approvals
NUROFEN ZAVANCE 256mg ibuprofen sodium sugar coated tablet blister pack - TGA Drug Approval Details
